CompletedNo phase
VIVO European Observational Registry
Key facts
- Who runs it
- Catheter Precision. Inc.
- Where
- Ireland, Italy, Netherlands, Portugal, and United Kingdom8 sites in 5 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 125 people enrolled
- Started
- 21 Oct 2021
- Ended
- 28 Sept 2024
- Type of study
- Observational
- Treatments tested
- VIVO
- Record updated
- 31 January 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Patients must at least 18 years of age Patients who have signed an IRB/EC approved patient informed consent and applicable patient privacy protection authorization per local law
- Patients who have previously had contrast cardiac imaging or will have cardiac imaging ordered per standard of care
- Patients will be selected without regard to gender
Who cannot take part
- Patients that are unable to receive contrast cardiac imaging (MR or CT)
This trial has no sites in United States.
It has sites in 5 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
A multi-center, observational registry conducted in Europe and the UK to prospectively review VIVO in a clinical setting in 125 patients.
Treatments tested
- VIVO
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- VIVO in a Practical Clinical Experience
- Record updated
- 31 January 2025